-transparent.png){kind=logo}
OBJECTIVE To characterise a newly developed mouse monoclonal antibody JC1 which recognises a nuclear antigen present in proliferating cells in normal tissues and neoplastic lesions, and which is absent in resting cells. METHODS The methodology was established using a representative range of frozen sections from normal tissues and from certain tumours which were immunostained with antibodies Ki67 and JC1. The molecular weight of the antigen recognised by JC1 was obtained by western blot analysis and this was compared with that of Ki67. IM-9 cell lysates containing Ki67 derived plasmids were also tested with JC1 antibody. RESULTS Biochemical investigation indicated that the antigen recognised by JC1 gives two molecular weight bands of 212 and 123 kilodaltons, which is distinct from the well characterised anti-proliferation monoclonal antibody Ki67 (395-345 kilodaltons). In addition recombinant Ki67 protein is not recognised by JC1. Immunohistological reactivity was seen in areas known to contain numerous proliferating cells such as lymphoid germinal centres, splenic white matter, cortical thymocytes and undifferentiated spermatogonia. In tumours many cells from adenocarcinomas, oat cell carcinomas, squamous cell carcinomas of lung, and seminomas were labelled by JC1 with a distribution and proportion similar to that seen with Ki67. In normal tissues the only apparent difference was in testis where JC1 stained a considerably greater number of cells than Ki67. In all cases studied the new antibody showed nuclear reactivity only. JC1 did not show any cytoplasmic crossreactivity with squamous cells as is frequently seen with Ki67. CONCLUSIONS Antibody JC1, which recognises a nuclear antigen present in proliferating cells, should provide a useful adjunct to Ki67 as a marker of proliferation especially in those cases such as squamous cell carcinomas where a Ki67 index cannot be determined.
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
September 1981,
Lancet (London, England),
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
August 1983,
The Journal of biological chemistry,
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
October 1982,
Science (New York, N.Y.),
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
May 1994,
Farmaco (Societa chimica italiana : 1989),
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
January 2008,
Cell cycle (Georgetown, Tex.),
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
January 1993,
Diagnostic microbiology and infectious disease,
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
November 1998,
Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
January 1987,
Vox sanguinis,
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
November 1991,
Tissue antigens,
M C Garrido, and
J L Cordell, and
M H Becker, and
G Key, and
J Gerdes, and
M Jones, and
K C Gatter, and
D Y Mason
January 1983,
Clinical and experimental immunology,
